Across TCGA pan-cancer cohorts, RNU6-775P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-775P data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-775P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-775P expression acts as an unfavorable survival marker, although some lineages such as ESCA and LAML show a favorable association.
KIRC, ESCA, and LAML are the cancer types where RNU6-775P RNA most reproducibly stratifies survival.